Dirk Sauer is an independent development expert for ophthalmology and a retired Novartis executive. They currently serve as chairman of the board for Dopavision and PulseSight Therapeutics. They have more than 31 years of experience in pharmaceutical research and development, leading projects and teams across Neuroscience and Ophthalmology. They earned a Pharmacy degree from the University of Münster and a Ph.D. in Pharmacology from Philipps-Universität Marburg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices